Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
2.59M
-
Number of holders
-
0
-
Total 13F shares, excl. options
-
0
-
Shares change
-
-3.97M
-
Total reported value, excl. options
-
$0
-
Value change
-
-$893K
-
Number of sells
-
-20
Significant Holders of Aptose Biosciences Inc. - Common Shares (APTO) as of Q1 2025
20 filings reported holding APTO - Aptose Biosciences Inc. - Common Shares as of Q1 2025.
Aptose Biosciences Inc. - Common Shares (APTO) has 0 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 0 shares
of 2.59M outstanding shares and own 0% of the company stock.
Largest 10 shareholders include Gleason Group, Inc. (0 shares), Pacific Capital Wealth Advisors, Inc. (0 shares), HighMark Wealth Management LLC (0 shares), Sigma Planning Corp (0 shares), SBI Securities Co., Ltd. (0 shares), Cetera Investment Advisers (0 shares), US BANCORP \DE\ (0 shares), TD Waterhouse Canada Inc. (0 shares), Annandale Capital, LLC (0 shares), and UBS Group AG (0 shares).
This table shows the top 0 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.